Skip to main content

Table 1 Characteristics of Cohort at Initial Diagnosis of SLE

From: Predictors of arthritis in pediatric patients with lupus

 

No Arthritis during follow-up

Arthritis present during follow-up

P-value

N = 25

N = 22

Age, years (SD)

12.5 (3.5)

11.8 (4.2)

0.6

Gender, n (%) F

22 (88)

20 (90)

0.9

Race, % AA

17 (68)

14 (64)

0.3

ANA, n (%) positive

25 (100)

22 (100)

-

dsDNA, n (%) positive

21 (84)

15 (68)

0.4

Ro, n (%) positive

7/18 (39)

1/6 (16)

0.4

La, n (%) positive

5/18 (28)

0/6 (0)

0.1

RNP, n (%) positive

9/20 (45)

5/9 (55)

0.5

Sm, n (%) positive

11/20 (55)

4/8 (50)

0.4

Low C3, n (%)

21 (84)

13 (59)

0.8

Low C4, n (%)

15 (60)

13 (59)

0.8

Elevated CRP, n (%)

13 (52)

2 (9)

0.02

Elevated ESR, n (%)

18 (72)

13 (59)

0.4

Renal disorder, n (%)

16 (64)

9 (41)

0.8

Hematologic disorder, n (%)

11 (44)

4 (18)

0.2

Fever, n (%)

4 (16)

4 (18)

0.4

Malar rash, n (%)

4 (16)

11 (50)

0.02

Mucosal ulcerations, n (%)

2 (8)

2 (9)

0.6

Alopecia, n (%)

22 (88)

2 (9)

0.007

Mean SLEDAI

12.8 ± 14.2

10.7 ± 11.7

0.6

Mean SLAM

5.1 ± 3.6

5.4 ± 3.1

0.6

  1. Laboratory values, SLEDAI, and SLAM scores were taken from the first presentation to the clinic. Renal, hematologic, skin, and integument involvement were defined as present if noted at any time during longitudinal follow-up